Evidence map›Paper›PMID 40533235›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Secondary Membranous Nephropathy Associated with Mycobacterium intracellulare.

Masaru Ando, Honoka Nagase, Toshifumi Shibata, Izumi Yamatani, Takamasa Kan, Erika Omote, Yuko Suenaga, Naoya Fukunaga, Eisuke Katafuchi, Toshiyuki Nakayama and 1 more

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masaru AndoDepartment of Respiratory Medicine, Oita Prefectural Hospital, Japan.
Honoka NagaseDepartment of Respiratory Medicine, Oita Prefectural Hospital, Japan.
Toshifumi ShibataDepartment of Respiratory Medicine, Oita Prefectural Hospital, Japan.
Izumi YamataniDepartment of Respiratory Medicine, Oita Prefectural Hospital, Japan.
Takamasa KanDepartment of Respiratory Medicine, Oita Prefectural Hospital, Japan.
Erika OmoteDepartment of Respiratory Medicine, Oita Prefectural Hospital, Japan.
Yuko SuenagaDepartment of Nephrology, Oita Prefectural Hospital, Japan.
Naoya FukunagaDepartment of Nephrology, Oita Prefectural Hospital, Japan.
Eisuke KatafuchiDepartment of Pathology, School of Medicine, University of Occupational and Environmental Health, Japan.
Toshiyuki NakayamaDepartment of Pathology, School of Medicine, University of Occupational and Environmental Health, Japan.
Kosaku KomiyaDepartment of Respiratory Medicine and Infection Diseases, Oita University Faculty of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 67-year-old woman was diagnosed with chronic bronchitis after an abnormality on chest radiography. Two years later, proteinuria was noted, and she was diagnosed with nephrosis the following year. Membranous nephropathy associated with Mycobacterium intracellulare was confirmed and clarithromycin, ethambutol and rifampicin were administered. She recovered from nephrosis after two years of anti-mycobacterial treatment. Successful treatment of the underlying cause of secondary membranous nephropathy may result in a cure. Membranous nephropathy due to mycobacteria is a rare condition. To our knowledge, this is the first report of membranous nephropathy associated with M. intracellulare.

Indexed as

Glomerulonephritis, MembranousMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionAgedClarithromycinEthambutolFemaleHumansClarithromycinEthambutolMycobacterium intracellularenephrosissecondary membranous nephropathy

Identifiers

PMID40533235
PMCPMC12900600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.